LifeStance Health Group, Inc. announced on February 25, 2026, that it entered into an Underwriting Agreement for the offering of 25,000,000 shares of its common stock, with 7,000,000 shares being repurchased from the underwriter. The offering closed on March 2, 2026, with no proceeds received by the company.